Saulnier, Mark G.
236  Ergebnisse:
Personensuche X
?
1

Discovery and Preclinical Profiling of GSK3839919, a Potent..:

Parcella, Kyle ; Wang, Tao ; Eastman, Kyle...
ACS Medicinal Chemistry Letters.  13 (2022)  6 - p. 972-980 , 2022
 
?
 
?
3

Insulin-like growth factor-1 receptor (IGF-1R) kinase inhib..:

Velaparthi, Upender ; Saulnier, Mark G. ; Wittman, Mark D....
Bioorganic & Medicinal Chemistry Letters.  20 (2010)  10 - p. 3182-3185 , 2010
 
?
4

SAR of PXR transactivation in benzimidazole-based IGF-1R ki..:

Zimmermann, Kurt ; Wittman, Mark D. ; Saulnier, Mark G....
Bioorganic & Medicinal Chemistry Letters.  20 (2010)  5 - p. 1744-1748 , 2010
 
?
6

2-(1H-Imidazol-4-yl)ethanamine and 2-(1H-pyrazol-1-yl)ethan..:

Saulnier, Mark G. ; Frennesson, David B. ; Wittman, Mark D....
Bioorganic & Medicinal Chemistry Letters.  18 (2008)  5 - p. 1702-1707 , 2008
 
?
7

Balancing oral exposure with Cyp3A4 inhibition in benzimida..:

Zimmermann, Kurt ; Wittman, Mark D. ; Saulnier, Mark G....
Bioorganic & Medicinal Chemistry Letters.  18 (2008)  14 - p. 4075-4080 , 2008
 
?
9

Discovery of a 1H-Benzoimidazol-2-yl)-1H-pyridin-2-one (BMS..:

Wittman, Mark ; Carboni, Joan ; Attar, Ricardo...
Journal of Medicinal Chemistry.  48 (2005)  18 - p. 5639-5643 , 2005
 
1-15